Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference57 articles.
1. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999
2. Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes;Raza;Blood,2001
3. Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome;Strupp;Leukemia,2003
4. A review of the history, properties, and use of the immunomodulatory compound lenalidomide;Zeldis;Ann N Y Acad Sci,2011
5. Recent clinical studies of the immunomodulatory drug (imid) lenalidomide;Bartlett;Br J Cancer,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Context is everything: aneuploidy in cancer;Nature Reviews Genetics;2019-09-23
2. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs;Cardiovascular & Hematological Disorders-Drug Targets;2019-01-28
3. Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency;European Journal of Haematology;2018-05-22
4. Myelodysplastic Syndrome With Isolated del(5q);Diagnostic Pathology: Blood and Bone Marrow;2018
5. Biology of Erythropoiesis, Erythroid Differentiation, and Maturation;Hematology;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3